Bedminster, NJ, United States of America

John Paolino

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Amei Technologies, Inc., Orthofix S.r.l.. Active years: 2016-2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Paolino: Innovator in Orthopedic Implantable Device Technology

Introduction

John Paolino is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of orthopedic implantable device technology. With a total of 2 patents, Paolino has focused on developing innovative solutions that enhance medical practices.

Latest Patents

His latest patents include advancements in variable angle screws, plates, and systems. The present disclosure relates, according to some embodiments, to orthopedic implantable device technology, specifically to variable angle implantable devices, systems, and methods. These inventions aim to improve the functionality and effectiveness of orthopedic implants.

Career Highlights

Throughout his career, John Paolino has worked with reputable companies such as Orthofix S.r.l. and Amei Technologies, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the medical field.

Collaborations

Paolino has collaborated with notable professionals in the industry, including John Lovell and Guy F. Birkenmeier. These partnerships have fostered a creative environment that encourages the development of advanced medical technologies.

Conclusion

John Paolino's work in orthopedic implantable device technology showcases his dedication to innovation and improvement in medical practices. His contributions continue to impact the field positively, making him a significant figure in the realm of medical inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…